Cargando…
Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
Objective: Indolent T-lymphoblastic proliferation (iT-LBP) is a non-neoplastic disease with an indolent clinical course, manifesting as hyperplasia of immature extrathymic T-lymphoblastic cells. Isolated iT-LBP has been observed, but the majority of iT-LBP cases has been seen in conjunction with oth...
Autores principales: | Han, Wen, Wang, Bei, Yong, Xiang, Zhang, Yi, Shao, Mingyu, Wang, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213281/ https://www.ncbi.nlm.nih.gov/pubmed/37252318 http://dx.doi.org/10.3389/pore.2023.1611151 |
Ejemplares similares
-
Molecular Basis of Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma
por: Surjan, Rodrigo Cañada T, et al.
Publicado: (2023) -
Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma
por: Yu, Tao, et al.
Publicado: (2022) -
Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing
por: Chen, Wenbiao, et al.
Publicado: (2022) -
Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021) -
Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma
por: Bang, Seongsik, et al.
Publicado: (2022)